The decision whether or not to treat patients with portal vein thrombosis is frequently encountered and remains a challenge.
C. Andrew Kistler, MD, PharmD
Andy authors Cancer Therapy Advisor's "In the Clinic" column. He is a gastroenterologist with interests in GI oncology, immunotherapy, the gut microbiome, and clinical pharmacology.
